Skip to content

Clinical trials

Completed Metabolism, Inborn Errors trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Status: Completed Country / region: Germany Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20141
20151
20171
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals2
Alexion Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
Sumitomo Pharma Switzerland GmbH1
medac GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors6
Genetic Diseases, Inborn5
Metabolic Diseases5
Musculoskeletal Diseases3
Arthritis2
Gout2
Infant, Newborn, Diseases2
Joint Diseases2
Lipid Metabolism Disorders2
Lipidoses2

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.